Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Preliminary phase II results promising for Maxamine in HCV

Nov. 11, 1999

Dainippon discloses new compounds useful for the treatment or prophylaxis of liver disease

Nov. 10, 1999

Anti-H. pylori compound isolated from Acinetobacter at Takeda laboratories

Nov. 10, 1999

Incara begins clinical program for IBD, explores strategic alternatives

Nov. 9, 1999

TKS-159: metabolism of new GI prokinetic agent and comparison with other benzamides

Nov. 8, 1999

Manipulation of the cytokine pathway: an effective strategy for preventing pancreatitis?

Nov. 5, 1999

Diacol is as effective as standard purgative therapy, with better patient preference, compliance

Nov. 5, 1999

Promising drug targets in HCV identified by Schering-Plough

Nov. 5, 1999

Tegaserod is highly effective and well tolerated in large North American study

Nov. 4, 1999

Zeffix approved in Taiwan for chronic HBV infection

Nov. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...